Abstract
The objective of the present study was to examine and determine whether the human acute monocytic leukemia cell line THP-1 contains side population (SP) cells, and, if so, to increase the proportion of SP cells using arabinosylcytosine (Ara-C). Fluorescent microscopy and flow cytometry were employed to detect the percentage of SP cells in THP-1 cells. Then, SP and non-SP (NSP) cell subpopulations were collected and identified. THP-1 cells were incubated with different concentrations of Ara-C for 24 h and the proportion of SP cells was detected. Our results demonstrated that the percentage of SP cells was 1.81 ± 0.99% in THP-1 cells. A majority of the SP cells remained in the G₀/G₁ phase, and the expression of CD34⁺ and CD34⁺CD38⁻ and the proliferation ability of the SP cells were higher compared to NSP cells (P<0.05). The mRNA expression of multidrug resistance genes (ABCG2 and ABCB1), apoptosis regulation genes (Bcl-2) and the Bcl-2/Bax value of SP cells were higher than those of NSP cells. SP cells have been shown to be more tumorigenic than NSP cells. Following co-culture with Ara-C, the proportion of SP cells increased significantly and subsequently the Ara-C concentration increased. These findings suggest that the THP-1 cell line contains SP cells and that SP cells possess certain intrinsic stem cell properties and may contain a larger proportion of leukemia stem cells (LSCs). The concentrations of SP cells can be increased with Ara-C by co-culture, and this technique is a useful and important application for the study of LSCs.
MeSH terms
-
ATP Binding Cassette Transporter, Subfamily B
-
ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
-
ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
-
ATP Binding Cassette Transporter, Subfamily G, Member 2
-
ATP-Binding Cassette Transporters / genetics
-
ATP-Binding Cassette Transporters / metabolism
-
Antigens, CD / genetics
-
Antigens, CD / metabolism
-
Carcinogenesis / genetics
-
Carcinogenesis / metabolism
-
Carcinogenesis / pathology
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Cytarabine / pharmacology
-
G1 Phase / drug effects
-
G1 Phase / genetics
-
Gene Expression
-
Humans
-
Leukemia, Monocytic, Acute / genetics
-
Leukemia, Monocytic, Acute / metabolism
-
Leukemia, Monocytic, Acute / pathology*
-
Neoplasm Proteins / genetics
-
Neoplasm Proteins / metabolism
-
Neoplastic Stem Cells / drug effects
-
Neoplastic Stem Cells / metabolism
-
Neoplastic Stem Cells / pathology
-
Proto-Oncogene Proteins c-bcl-2 / genetics
-
Proto-Oncogene Proteins c-bcl-2 / metabolism
-
RNA, Messenger / genetics
-
Side-Population Cells / drug effects
-
Side-Population Cells / metabolism
-
Side-Population Cells / pathology*
-
bcl-2-Associated X Protein / genetics
-
bcl-2-Associated X Protein / metabolism
Substances
-
ABCB1 protein, human
-
ABCG2 protein, human
-
ATP Binding Cassette Transporter, Subfamily B
-
ATP Binding Cassette Transporter, Subfamily B, Member 1
-
ATP Binding Cassette Transporter, Subfamily G, Member 2
-
ATP-Binding Cassette Transporters
-
Antigens, CD
-
Neoplasm Proteins
-
Proto-Oncogene Proteins c-bcl-2
-
RNA, Messenger
-
bcl-2-Associated X Protein
-
Cytarabine